Laurion Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,248
| Closed | -$585K | – | 472 |
|
|
2024
Q2 | $585K | Sell |
1,248
-65,645
| -98% | -$30.8M | 0.01% | 231 |
|
|
2024
Q1 | $28M | Buy |
+66,893
| New | +$28M | 0.24% | 39 |
|
|
2022
Q4 | – | Sell |
-705
| Closed | -$204K | – | 314 |
|
|
2022
Q3 | $204K | Buy |
+705
| New | +$204K | ﹤0.01% | 223 |
|
|
2022
Q2 | – | Sell |
-11,949
| Closed | -$3.12M | – | 555 |
|
|
2022
Q1 | $3.12M | Buy |
+11,949
| New | +$3.12M | 0.04% | 88 |
|
|
2020
Q4 | – | Sell |
-73,975
| Closed | -$20.1M | – | 738 |
|
|
2020
Q3 | $20.1M | Buy |
+73,975
| New | +$20.1M | 0.24% | 31 |
|
|
2019
Q4 | – | Sell |
-2,675
| Closed | -$453K | – | 853 |
|
|
2019
Q3 | $453K | Buy |
+2,675
| New | +$453K | ﹤0.01% | 401 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 965 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1146 |
|
|
2017
Q4 | – | Sell |
-5,700
| Closed | -$867K | – | 1386 |
|
|
2017
Q3 | $867K | Sell |
5,700
-16,882
| -75% | -$2.57M | ﹤0.01% | 589 |
|
|
2017
Q2 | $2.91M | Sell |
22,582
-235,800
| -91% | -$30.4M | 0.02% | 309 |
|
|
2017
Q1 | $28.3M | Buy |
+258,382
| New | +$28.3M | 0.21% | 26 |
|
|
2015
Q3 | – | Sell |
-2,417
| Closed | -$298K | – | 649 |
|
|
2015
Q2 | $298K | Buy |
+2,417
| New | +$298K | ﹤0.01% | 246 |
|